Age-adjusted dementia deaths rates were stable between 2018 and 2019, then increased in 2020 and decreased slightly in 2022, ...

In the last two years, two drugs have been federally approved to slow the onset of Alzheimer's disease in its early stages, ...

“This is part of our commitment to delivering Smarter AI for All—developing and deploying technology that can empower ...

A new study has found frailty increases a person's risk of dementia, but early intervention may be the key to prevention.

A recent study has discovered a food linked to increased dementia risk. Presented at the 2024 Alzheimer's Association International Conference in July, the research pointed to processed red meat.

Research shows frailty levels rise significantly before dementia, suggesting it could be a key marker for early ...

1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...

The CHMP recommends approval of lecanemab for the treatment of mild cognitive impairment (MCI) and mild dementia caused by Alzheimer's disease, in adult patients who are heterozygotes (carry one copy) ...

The latest is no exception, as it features the youngest of the Willis ladies, Evelyn Penn, who is ten. In addition to the ...

Data from INVOKE-2, evaluating TREM2 agonist candidate AL002 in patients with early Alzheimer’s disease (AD), on track for 2024Participant ...

Gaugler said understanding why interventions work will open doors for those with dementia and their caregivers. “If you know how or why an intervention works, what essential elements are, then when ...

It is important to distinguish between cognitive decline, which is considered a normal part of aging, and dementia, which is not ... Nikky Contractor, PhD, the global R&D leader at Amway, not involved ...